Leadership Team

A lifelong healthcare executive with leadership experience at global pharmaceutical and medical device companies, David J. Endicott is the Chief Executive Officer of Alcon and brings to the Board an in-depth knowledge of Alcon as well as the healthcare industry. He joined the Alcon Division, when still operating under the Novartis group, in July 2016 as President, Commercial and Innovation, and Chief Operating Officer. Prior to joining the Alcon Division in 2016, Mr. Endicott was President of Hospira Infusion Systems, a Pfizer company. Before joining Hospira, Mr. Endicott served as an officer and executive committee member of Allergan, Inc. where he spent more than 25 years of his career in leadership roles across Europe, Asia and Latin America, as well as the U.S. Mr. Endicott served on the board of directors of Zeltiq, Inc. and Orexigen Therapeutics, Inc. He currently serves on the board of AdvaMed.

He holds an undergraduate degree in Chemistry from Whitman College and a Master’s degree in Business Administration from the University of Southern California, both in the United States

Laurent Attias is Head of Corporate Development, Strategy, BD&L and M&A where he leads the development of long-term strategic plans for the Surgical and Vision Care franchises of Alcon and is responsible for the Alcon’s BD&L, M&A, partnerships and alliance activities, a role which he has held since 2012. Since 1994 when Mr. Attias joined Alcon, he has had various roles with increasing responsibility beginning with positions in Alcon’s Sales and Marketing functions and then holding the positions of Vice President, Refractive Sales and Marketing from 2002 to 2007; Vice President/General Manager of Alcon Canada from 2007 to 2009; Vice President, Central & Eastern Europe, Italy and Greece from 2009 to 2010; and President, Europe, Middle East and Africa (“EMEA”) from 2010 to 2012.

Mr. Attias holds both a Bachelor of Business Administration in Marketing and a Master of Business Administration from Texas Christian University in the United States.

Heather Attra is Senior Vice President, Global Head Quality and Regulatory Affairs for Alcon. Ms. Attra joined Novartis in 2010 as the Ciba Vision Head of Quality for the Americas. She later served as Ciba Vision’s Vice President of Compliance, Alcon’s Vice President of Quality for both the Vision Care and Surgical franchises and Global Head of Manufacturing and Technical Operations for Alcon’s Vision Care franchise. Most recently, Ms. Attra held the position of SVP, Head Global Quality. Prior to joining Alcon, Ms. Attra has held a variety of quality management positions of increasing responsibility at Catalent Pharma Solutions.

Ms. Attra holds a Bachelor of Science degree in Biomedical Science from Texas A&M in College Station, Texas.

Jeannette Bankes is President & General Manager, Global Surgical Franchise for Alcon. Prior to joining Alcon, Ms. Bankes was General Manager, Urology & Pelvic Health for Boston Scientific, where she was responsible for the entire scope of the global business including commercial sales, marketing, R&D, regulatory, operations, manufacturing, supply chain, quality, clinical research, and new business development. During her 15-year tenure at Boston Scientific, Ms. Bankes served as Vice President of Clinical & Regulatory Affairs, Director of Scientific Communications, and Director of Medical Affairs. Ms. Bankes began her career with Merck & Co., where she held diverse roles of increasing responsibility in sales, marketing, clinical and biological manufacturing.

Ms. Bankes holds a Bachelor of Science in Biochemistry & Medical Technology from Kutztown University.

Royce Bedward is Senior Vice President, General Counsel and Corporate Secretary for Alcon. Mr. Bedward joined Alcon in 2016 from Hospira, where he played a key role in the company’s turnaround, overseeing M&A, securities, litigation, regulatory and compliance matters. He joined Hospira in 2004 as Vice President of Litigation and Human Resources and led its spin-off from Abbott Laboratories.

Mr. Bedward holds a Bachelor’s degree in Business Administration from Saint Norbert College, De Pere, Wisconsin, and a Juris Doctor degree from the University of Illinois College of Law, Champaign, Illinois.

Ian Bell has been the President, Global Business & Innovation since September 2021 where he oversees the development of new products and digital health solutions as well as the Alcon Surgical and Vision Care businesses. From January 2019 until he was appointed to his current role, he was President-International, overseeing the Europe, Russia, Middle East and Africa, Asia Pacific, Japan and Latin America and Caribbean markets. He joined Alcon in March 2016 as President of EMEA. From 2014 until joining Alcon, Mr. Bell served as Corporate Vice President and President of the EMEA region for Hospira. Mr. Bell was Corporate Vice President and President of Allergan, Inc.’s Asia Pacific region, based in Singapore, from 2008 to 2014. Mr. Bell joined Allergan in 2005 as Vice President and Managing Director of its neurosciences division for the EMEA region. He began his career at GlaxoSmithKline, where he held roles of increasing responsibility and scope in sales, marketing and strategy for more than 10 years.

Mr. Bell was awarded the degree of Bachelor of Arts with honors in Economics from the University of York in the United Kingdom.

Sergio Duplan has served as President-North America, overseeing the United States and Canada markets since 2015. Mr. Duplan joined Alcon in 2012 and served as Alcon’s President of Latin America and Canada for Alcon for three years. Mr. Duplan began his career with Novartis in 2004, as Vice President of Sales in General Medicines, in Mexico then served as Head of Marketing and Sales for Latin America, General Medicines, Pharma from 2006 to 2008 and then Country Pharma Organization Head and Country President of Novartis Mexico from 2008 to 2012. Prior to joining Novartis, Mr. Duplan held several positions of increasing responsibility in Sales, Finance and Country Management at Procter & Gamble and Eli Lilly & Co. He is also currently a board member of The Alcon Foundation.

Mr. Duplan holds a Bachelor degree in Industrial Engineering from Universidad Iberoamericana in Mexico and a Master of Business Administration from The Wharton School at the University of Pennsylvania in the United States.

Franck Leveiller is Senior Vice President, Head Global R&D, and Chief Scientific Officer for Alcon. Mr. Leveiller joined Alcon in June 2011 as VP and Head of R&D Vision Care, and in June 2015 assumed the role of Head, R&D Surgical Franchise at Alcon. Before joining Alcon, Mr. Leveiller was the Global Head of R&D at Ciba Vision, after two years with Novartis Pharmaceuticals as Global Head Technical R&D, Project Management. Prior to Novartis, he held R&D positions with pharmaceutical companies, such as AstraZeneca, Aventis and Rhône-Poulenc Rorer.

Franck has a Ph.D. in Physical Chemistry from the Weizmann Institute of Science, Israel, where he was awarded the John F. Kennedy Memorial prize for outstanding Ph.D. research work.

Sue-Jean Lin is Senior Vice President, Chief Information and Transformation Officer where she leads the technology initiatives within Alcon and is responsible for leading the development and implementation of Alcon’s transformation program. Ms. Lin joined Alcon in August 2018 as Senior Vice President, Chief Information Officer. Prior to joining Alcon, Ms. Lin was Senior Vice President and Chief Information Officer for Hill-Rom Holdings, Inc., a global medical technology company. Prior to joining Hill-Rom in 2016, she was the Senior Vice President and Chief Information Officer, and before that, the Vice President of Finance & Regional Controller (Europe, Middle East, and Africa and Asia Pacific) for Allergan, Inc. In 2015, she also served as Interim Executive for Presbyterian Healthcare Services in the capacity of Senior Vice President and Chief Information Officer.

Ms. Lin holds both a Bachelor’s degree in Accounting and a Master’s degree in Business Administration from the University of Nevada, Reno. She also completed the Executive Leadership Program from the University of Southern California, Marshall School of Business, and holds a Cybersecurity Oversight certificate from Software Engineering Institute of Carnegie Mellon University.

Kim Martin is the Senior Vice President and Chief Human Resources Officer for Alcon. Prior to joining Alcon, Ms. Martin was Chief Human Resources Officer for Worldpay, a $4 billion global payment processing and technology provider. She has also served as an executive human resources leader at Zimmer Holdings Inc., as well as more than 11 years in progressive human resources and talent acquisition positions at General Electric Healthcare.

Ms. Martin attended the University of Illinois, Champaign-Urbana, where she received her Bachelor of Arts in Speech Communications and her Masters in Labor and Industrial Relations.

Ed McGough is Alcon’s Senior Vice President of Global MTO. Mr. McGough joined Alcon in April 1991 as a Manager of Quality Assurance and Regulatory. Following this role, he held various positions at Alcon, including Director of Quality Assurance and Director of Operations. Mr. McGough has also served as Vice President and General Manager of Fort Worth and Houston manufacturing. Following this role, he served as Vice President, Manufacturing, Pharmaceutical Operations. Prior to joining Alcon, Mr. McGough served in various quality engineering/management roles with Baxter Healthcare Corporation.

Mr. McGough earned a Bachelor of Science in Industrial Engineering from Louisiana Tech University in 1983. He is also a 1999 graduate of the Stanford Executive Program.

Mr. Narayanan has been the President, International since September 2021 where he oversees the Europe, Russia, Middle East and Africa, Asia Pacific, China, Japan, Latin America and Caribbean markets. From April 2019 until he was appointed to his current role, he was Senior Vice President, Operational Strategy and Chief Transformation Officer and was responsible for leading the development and implementation of Alcon’s transformation program. He joined Alcon in June 2017 as President, Asia Pacific Region from Allergan, Inc., where he worked for 22 years in roles of increasing responsibility, including Senior Vice President, Asia Pacific Region from 2014 to 2017; Vice President and Managing Director of the Medical Aesthetic Franchise for Europe Africa and Middle East from 2011 to 2014; and Vice-President, Greater China & Japan from 2008 to 2011. Prior to those roles, Mr. Narayanan was a part of Allergan’s finance function in a number of country, region and corporate finance roles. Mr. Narayanan started his career in finance with Hindustan Unilever India in 1987.

Mr. Narayanan holds a Bachelor of Science degree in Accounting and Finance from Mumbai University. He is also Chartered Accountant and Cost and Works Accountant in India.

Tim Stonesifer has been the Chief Financial Officer since April 2019. Prior to joining Alcon, he had served as Executive Vice President and Chief Financial Officer at Hewlett Packard Enterprise from November 2015 through September 2018. Prior to that role, Mr. Stonesifer acted as Senior Vice President and Chief Financial Officer, Enterprise Group at HP Co. since 2014. Before joining HP Co., he served as Chief Financial Officer of General Motors’ International Operations from 2011 to 2014. Previously, he served as Chief Financial Officer of Alegco Scotsman, a storage company, from 2010 to May 2011; Chief Financial Officer of Sabic Innovative Plastics (formerly GE Plastics) from 2007 to 2010; and various other positions at General Electric since joining the company in 1989.

Mr. Stonesifer holds a Bachelor of Arts in Economics from the University of Michigan in the United States.